PF-03463275

PF-03463275 · Pfizer

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for PF-03463275, covering 2011-04-20 to 2012-02-07. Get the full timeline:

Most recent: Clinical Trial Update: A Study Of PF-03463275 As Add-On Therapy In Outpatients With Persistent Negative Symptoms Of Schizophrenia [Phase 2]

See pricing